These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 12107041)

  • 21. Predictors of acamprosate efficacy: results from a pooled analysis of seven European trials including 1485 alcohol-dependent patients.
    Verheul R; Lehert P; Geerlings PJ; Koeter MW; van den Brink W
    Psychopharmacology (Berl); 2005 Mar; 178(2-3):167-73. PubMed ID: 15322728
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of community nurse follow-up when treating alcohol dependence with acamprosate.
    Pelc I; Hanak C; Baert I; Houtain C; Lehert P; Landron F; Verbanck P
    Alcohol Alcohol; 2005; 40(4):302-7. PubMed ID: 15870092
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug therapy for alcohol dependence in primary care in the UK: A Clinical Practice Research Datalink study.
    Thompson A; Ashcroft DM; Owens L; van Staa TP; Pirmohamed M
    PLoS One; 2017; 12(3):e0173272. PubMed ID: 28319159
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Do acamprosate or naltrexone have an effect on daily drinking by reducing craving for alcohol?
    Richardson K; Baillie A; Reid S; Morley K; Teesson M; Sannibale C; Weltman M; Haber P
    Addiction; 2008 Jun; 103(6):953-9. PubMed ID: 18482418
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined efficacy of acamprosate and disulfiram in the treatment of alcoholism: a controlled study.
    Besson J; Aeby F; Kasas A; Lehert P; Potgieter A
    Alcohol Clin Exp Res; 1998 May; 22(3):573-9. PubMed ID: 9622434
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prescription procedures in medication for relapse prevention after inpatient treatment for alcohol use disorders in Switzerland.
    Buri C; Moggi F; Giovanoli A; Strik W
    Alcohol Alcohol; 2007; 42(4):333-9. PubMed ID: 17517820
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Do patients with alcohol dependence respond to placebo? Results from the COMBINE Study.
    Weiss RD; O'malley SS; Hosking JD; Locastro JS; Swift R;
    J Stud Alcohol Drugs; 2008 Nov; 69(6):878-84. PubMed ID: 18925346
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of acamprosate in the treatment of alcohol-dependent outpatients.
    Baltieri DA; de Andrade AG
    Braz J Psychiatry; 2003 Sep; 25(3):156-9. PubMed ID: 12975689
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acamprosate: A Review of Its Use in Alcohol Dependence.
    Plosker GL
    Drugs; 2015 Jul; 75(11):1255-68. PubMed ID: 26084940
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Naltrexone versus acamprosate: one year follow-up of alcohol dependence treatment.
    Rubio G; Jiménez-Arriero MA; Ponce G; Palomo T
    Alcohol Alcohol; 2001; 36(5):419-25. PubMed ID: 11524308
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is acamprosate use in alcohol dependence treatment reflected in improved subjective health status outcomes beyond cognitive behavioural therapy alone?
    Feeney GF; Connor JP; McD Young R; Tucker J; McPherson A
    J Addict Dis; 2006; 25(4):49-58. PubMed ID: 17088225
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of acamprosate on cognition in a treatment study of patients with schizophrenia spectrum disorders and comorbid alcohol dependence.
    Ralevski E; O'Brien E; Jane JS; Dean E; Dwan R; Petrakis I
    J Nerv Ment Dis; 2011 Jul; 199(7):499-505. PubMed ID: 21716064
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Searching for responders to acamprosate and naltrexone in alcoholism treatment: rationale and design of the PREDICT study.
    Mann K; Kiefer F; Smolka M; Gann H; Wellek S; Heinz A;
    Alcohol Clin Exp Res; 2009 Apr; 33(4):674-83. PubMed ID: 19170666
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The BRENDA model: integrating psychosocial treatment and pharmacotherapy for the treatment of alcohol use disorders.
    Starosta AN; Leeman RF; Volpicelli JR
    J Psychiatr Pract; 2006 Mar; 12(2):80-9. PubMed ID: 16728904
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of acamprosate on alcohol and food craving in patients with alcohol dependence.
    Han DH; Lyool IK; Sung YH; Lee SH; Renshaw PF
    Drug Alcohol Depend; 2008 Mar; 93(3):279-83. PubMed ID: 17983709
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acamprosate. A review of its pharmacology and clinical potential in the management of alcohol dependence after detoxification.
    Wilde MI; Wagstaff AJ
    Drugs; 1997 Jun; 53(6):1038-53. PubMed ID: 9179530
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of acamprosate on magnetic resonance spectroscopy measures of central glutamate in detoxified alcohol-dependent individuals: a randomized controlled experimental medicine study.
    Umhau JC; Momenan R; Schwandt ML; Singley E; Lifshitz M; Doty L; Adams LJ; Vengeliene V; Spanagel R; Zhang Y; Shen J; George DT; Hommer D; Heilig M
    Arch Gen Psychiatry; 2010 Oct; 67(10):1069-77. PubMed ID: 20921123
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A randomized, double-blind, placebo-controlled clinical trial of acamprosate in alcohol-dependent individuals with bipolar disorder: a preliminary report.
    Tolliver BK; Desantis SM; Brown DG; Prisciandaro JJ; Brady KT
    Bipolar Disord; 2012 Feb; 14(1):54-63. PubMed ID: 22329472
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acamprosate and its efficacy in treating alcohol dependent adolescents.
    Niederhofer H; Staffen W
    Eur Child Adolesc Psychiatry; 2003 Jun; 12(3):144-8. PubMed ID: 12768462
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combining psychosocial treatment with pharmacotherapy for alcohol dependence.
    Weiss RD; Kueppenbender KD
    J Clin Psychopharmacol; 2006 Dec; 26 Suppl 1():S37-42. PubMed ID: 17114954
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.